Nanocomposite alginate hydrogel loaded with propranolol hydrochloride kolliphor® based cerosomes as a repurposed platform for Methicillin-Resistant Staphylococcus aureus-(MRSA)-induced skin infection; in-vitro, ex-vivo, in-silico, and in-vivo evaluation
- PMID: 38762697
- DOI: 10.1007/s13346-024-01611-z
Nanocomposite alginate hydrogel loaded with propranolol hydrochloride kolliphor® based cerosomes as a repurposed platform for Methicillin-Resistant Staphylococcus aureus-(MRSA)-induced skin infection; in-vitro, ex-vivo, in-silico, and in-vivo evaluation
Abstract
Nanocomposite alginate hydrogel containing Propranolol hydrochloride (PNL) cerosomes (CERs) was prepared as a repurposed remedy for topical skin Methicillin-Resistant Staphylococcus aureus (MRSA) infection. CERs were formed via an ethanol injection technique using different ceramides, Kolliphores® as a surfactant, and Didodecyldimethylammonium bromide (DDAB) as a positive charge inducer. CERs were optimized utilizing 13. 22 mixed-factorial design employing Design-Expert® software, the assessed responses were entrapment efficiency (EE%), particle size (PS), and zeta potential (ZP). The optimum CER, composed of 5 mg DDAB, ceramide VI, and Kolliphor® RH40 showed tubular vesicles with EE% of 92.91 ± 0.98%, PS of 388.75 ± 18.99 nm, PDI of 0.363 ± 0.01, and ZP of 30.36 ± 0.69 mV. Also, it remained stable for 90 days and manifested great mucoadhesive aspects. The optimum CER was incorporated into calcium alginate to prepare nanocomposite hydrogel. The ex-vivo evaluation illustrated that PNL was permeated in a more prolonged pattern from PNL-loaded CERs nanocomposite related to PNL-composite, optimum CER, and PNL solution. Confocal laser scanning microscopy revealed a perfect accumulation of fluorescein-labeled CERs in the skin. The in-silico investigation illustrated that the PNL was stable when mixed with other ingredients in the CERs and confirmed that PNL is a promising candidate for curing MRSA. Moreover, the PNL-loaded CERs nanocomposite revealed superiority over the PNL solution in inhibiting biofilm formation and eradication. The PNL-loaded CERs nanocomposite showed superiority over the PNL-composite for treating MRSA infection in the in-vivo mice model. Histopathological studies revealed the safety of the tested formulations. In conclusion, PNL-loaded CERs nanocomposite provided a promising, safe cure for MRSA bacterial skin infection.
Keywords: MRSA skin infection; Alginate nanocomposite; Antibacterial; Biofilm; Confocal laser microscopy; In-silico study; In-vivo study; Propranolol hydrochloride; Topical drug delivery.
© 2024. The Author(s).
Similar articles
-
Integration of terpesomes loaded Levocetrizine dihydrochloride gel as a repurposed cure for Methicillin-Resistant Staphylococcus aureus (MRSA)-Induced skin infection; D-optimal optimization, ex-vivo, in-silico, and in-vivo studies.Int J Pharm. 2023 Feb 25;633:122621. doi: 10.1016/j.ijpharm.2023.122621. Epub 2023 Jan 21. Int J Pharm. 2023. PMID: 36693486
-
Chitosan decorated oleosomes loaded propranolol hydrochloride hydrogel repurposed for Candida albicans-vaginal infection.Nanomedicine (Lond). 2024 Jun 20;19(15):1369-1388. doi: 10.1080/17435889.2024.2359364. Epub 2024 Jun 20. Nanomedicine (Lond). 2024. PMID: 38900630
-
Utilization of propranolol hydrochloride mucoadhesive invasomes as a locally acting contraceptive: in-vitro, ex-vivo, and in-vivo evaluation.Drug Deliv. 2022 Dec;29(1):2549-2560. doi: 10.1080/10717544.2022.2100514. Drug Deliv. 2022. PMID: 35912869 Free PMC article.
-
Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: central composite design optimization, in- silico and in-vivo studies.Drug Deliv. 2022 Dec;29(1):2784-2795. doi: 10.1080/10717544.2022.2108939. Drug Deliv. 2022. PMID: 36047012 Free PMC article.
-
A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration.Drug Deliv. 2023 Dec;30(1):2179129. doi: 10.1080/10717544.2023.2179129. Drug Deliv. 2023. PMID: 36788709 Free PMC article. Review.
References
-
- Su R, Yang L, Wang Y, Yu S, Guo Y, Deng J, et al. Formulation, development, and optimization of a novel octyldodecanol-based nanoemulsion for transdermal delivery of ceramide IIIB. Int J Nanomed. 2017;12:5203–21. - DOI
LinkOut - more resources
Full Text Sources